Spring Mountain Capital — Full Portfolio
18 tracked investments · listed companies and verified rows first
Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.
BiotechDigital HealthHealthtechNew Haven, US
Paul Fonteyne(Co-Founder)inStephen Strittmatter(Scientific Founder)inStephen Bloch(CEO & Co-Founder)inTimothy Siegert(COO, Co-Founder)inTim Siegert, PhD(COO & Co-Founder)Jennifer Gabler(Executive Officer)in
Co-investorsElm Street VenturesConnecticut InnovationsWHIN
Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Tillman Gerngross(Executive Officer, Director)
BoardTerrance McGuire(Director)
Co-investorsGV (Google Ventures)Fidelity InvestmentsMithril Capital ManagementPolaris PartnersSands Capital Ventures
Data & InfrastructureTel Aviv, IL
Co-investorsTechstarsAllos VenturesBlue Heron CapitalGoldman SachsLiveOak Venture PartnersOhio Innovation Fund+2 more
EverWash offers a subscription service that partners with local car washes to provide members unlimited washes for a monthly fee through an app.
AI & Machine LearningConsumerMarketplacesMobility & TransportationSaaSPhiladelphia, US
Scott Caplan(Co-CEO, Treasurer, Secretary)inJohn Cassady(Co-CEO)inRaymond Wong(Director)Jerry Goldstein(Director)
Co-investorsFlow Capital
Eyrus is a construction workforce management platform that combines worker registration and onboarding, time tracking, access control, and video surveillance in one system.
AI & Machine LearningConstruction TechSaaS
Hussein Cholkamy(Founder)in
Co-investorsFuel Venture CapitalK Street CapitalMaryland TEDCOMotley Fool VenturesTEDCOTemerity Capital Partners
Genomenon uses AI to read biomedical literature and expert scientists to curate variant- and patient-level genomic evidence, delivering regulatory-grade real-world evidence.
AI & Machine LearningBiotechDigital HealthAnn Arbor, US
Mark Kiel(Chief Scientific Officer & Co-Founder)inEli Salembier(Executive Officer, Director)inSam Globus(Executive Officer)inDavid Gregorka(Director)inBrian Groark(Executive Officer)inMike Klein(Chief Executive Officer)in
Co-investorsBeringeaGreen Park & Golf VenturesID VenturesInvest MichiganIrishAngelsMarram Ventures+1 more
Hiveclass provides remote physical education and youth sports training instruction for kids.
EdTechFuture of WorkWellness & FitnessBridgehampton, US
Joe Titus(Founder)inPaul Suhr(Founder)in
Co-investorsSamvid VenturesTechstarsRethink Capital PartnersRethink Education
Prevalent, a Mitratech product, is an AI-powered third-party risk management (TPRM) platform for assessing, monitoring, and remediating risks across the vendor and supplier lifecycle from onboarding to offboarding.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaSPhoenix, US
Norman W. Menz, III(Director)Jonathan Dambrot(Director)Kevin Hickey(Chief Executive Officer)James Ray(Vice President of Finance, Corporate Secretary and Treasurer)Kevin Charest(Director)Doug McNary(Director)
Co-investorsFulcrum Equity PartnersTappan Hill Ventures
ProSomnus offers oral appliance devices for treating obstructive sleep apnea and snoring, positioned as an alternative to CPAP machines.
Digital HealthHealthtechMedical DevicesWellness & FitnessPleasanton, US
Leonard Liptak(Executive Officer, Director)Sung Kim(Executive Officer)Jason Orchard(Director)Steven Pacelli(Director)Heather Rider(Director)Laing Rikkers(Executive Officer, Director)
Co-investorsCatalio Capital Management, LPCatalio Capital Management
BiotechNew Haven, US
Erika Smith(Executive Officer, Director)George Maynard(Executive Officer)
BoardDavid Wurzer(Director)Gregory Ho(Director)John Puziss(Director)
Co-investorsConnecticut Innovations
New York, US
Edward Kim(Executive Officer, Director)Kent Krekorian(Executive Officer)inHal Muchnick(Executive Officer, Director)in
BoardBo Peabody(Director)Benjamin Sun(Director)Kirk Wolfe(Director)in
Co-investorsMI VenturesSocial StartsAtlas VentureMK Capital
Vergent develops tumor-targeted fluorescent imaging agents designed to enhance surgeons' ability to visualize tumors during minimally invasive and robotic-assisted cancer surgery.
BiotechDeep TechHealthtechMedical DevicesMinneapolis, US
Jeffrey Yurecko(Executive Officer)John Santini(Executive Officer, Director)John Santini, PhD(President and Chief Executive Officer)
BoardJeff Julkowski(Director)Raymond Wong(Director)Anita Watkins(Director)in
Co-investorsColle Capital PartnersWindham Capital Partners
QUODD delivers financial market data on demand—including global pricing, reference data, and real-time streaming feeds—to financial institutions, back and middle office teams, and fintech startups.
Data & InfrastructureEnterprise SoftwareFintech
Co-investorsVlad TenevQUICKStarVest Partners
Yunu offers a clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission, cutting turnaround times and reducing manual work.
AI & Machine LearningBiotechHealthtechMedical DevicesSaaS
Jeffrey Sorenson(Chief Executive Officer)inGael Kuhn(Chief Technology Officer)inDr. Gordon Harris(Chief Science Officer)Lindsay Fleming(Chief Marketing Officer)inPatrick McNamara(Chief Commercial Officer)in
Co-investorsFirst Analysis
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.